News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,877 Results
Type
Article (2420)
Company Profile (39)
Press Release (35418)
Section
Business (14135)
Career Advice (77)
Deals (2088)
Drug Delivery (8)
Drug Development (4099)
Employer Resources (10)
FDA (432)
Job Trends (761)
News (20160)
Policy (1055)
Tag
Academia (144)
Alliances (3468)
Alzheimer's disease (45)
Antibody-drug conjugate (ADC) (14)
Approvals (434)
Bankruptcy (11)
Best Places to Work (475)
Biosimilars (10)
Biotechnology (29)
Breast cancer (15)
Cancer (104)
Career advice (64)
CAR-T (12)
Cell therapy (35)
Clinical research (3145)
Collaboration (79)
Compensation (36)
COVID-19 (179)
C-suite (21)
Data (82)
Diagnostics (461)
Duchenne muscular dystrophy (9)
Earnings (4174)
Events (5948)
Executive appointments (75)
FDA (469)
Funding (67)
Gene editing (13)
Gene therapy (13)
GLP-1 (59)
Government (146)
Healthcare (705)
Infectious disease (184)
Inflammatory bowel disease (11)
Intellectual property (9)
IPO (999)
Job creations (290)
Job search strategy (62)
Layoffs (36)
Legal (212)
Lung cancer (15)
Manufacturing (17)
Medical device (357)
Medtech (357)
Mergers & acquisitions (1141)
Metabolic disorders (27)
Neuroscience (83)
NextGen: Class of 2025 (353)
Non-profit (154)
Northern California (291)
Obesity (13)
Opinion (14)
Patents (14)
People (5604)
Phase I (1354)
Phase II (1584)
Phase III (840)
Pipeline (45)
Postmarket research (30)
Preclinical (582)
Radiopharmaceuticals (12)
Rare diseases (17)
Real estate (419)
Regulatory (794)
Research institute (143)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (20)
Southern California (284)
Startups (487)
United States (1384)
Vaccines (24)
Weight loss (9)
Date
Today (8)
Last 7 days (59)
Last 30 days (180)
Last 365 days (2558)
2025 (328)
2024 (2615)
2023 (2868)
2022 (3767)
2021 (4063)
2020 (3497)
2019 (2076)
2018 (1561)
2017 (1802)
2016 (1626)
2015 (1835)
2014 (1370)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1182)
Location
Africa (43)
Arizona (14)
Asia (1847)
Australia (295)
California (663)
Canada (120)
China (32)
Colorado (15)
Connecticut (9)
Europe (3854)
Florida (39)
Illinois (13)
Indiana (26)
Kansas (12)
Maryland (22)
Massachusetts (234)
Minnesota (14)
New Jersey (48)
New York (38)
North Carolina (80)
Northern California (291)
Ohio (24)
Pennsylvania (31)
South America (41)
Southern California (284)
Texas (54)
Washington State (36)
37,877 Results for "hummingbird bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hummingbird Bioscience Licenses Novel Antibodies to Immunome
January 7, 2025
·
2 min read
Hummingbird Bioscience Presents New Preclinical Data Highlighting Next-Generation Antibody-Drug Conjugate Capabilities at PEGS Boston 2024
Data highlights potential of Hummingbird Bioscience’s dual-payload antibody-drug conjugate platform to improve upon the current generation of ADCs
May 13, 2024
·
4 min read
Press Releases
Hummingbird Bioscience Announces Key Leadership Appointments
July 29, 2024
·
2 min read
Press Releases
Hummingbird Bioscience Announces Poster Presentation on HMBD-802, Novel Dual-Payload Antibody-Drug Conjugate, at EORTC-NCI-AACR 2024
October 24, 2024
·
2 min read
BioCapital
Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024
Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024.
March 13, 2024
·
4 min read
Biotech Bay
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024
Hummingbird Bioscience announced two upcoming poster presentations at the American Association for Cancer Research Meeting 2024 in San Diego, California.
March 5, 2024
·
6 min read
Business
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
Hummingbird Bioscience announced the appointment of Angèle Maki, Ph.D., as Chief Business Officer, effective immediately.
December 11, 2023
·
2 min read
Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine to Co-Host 3rd Annual Virtual VISTA Symposium on March 27, 2024
SINGAPORE and HANOVER, March 13, 2024 – Hummingbird Bioscience and Dartmouth’s Geisel School of Medicine today announced that the 3rd Annual VISTA Symposium will take place virtually on Wednesday, March 27, 2024 (11:00 AM - 3:30 PM ET).
March 13, 2024
·
4 min read
Business
Endeavor BioMedicines Enters License Agreement with Hummingbird Bioscience for Worldwide Rights to HMBD-501, a Next Generation HER3-Targeted Antibody-Drug Conjugate (ADC)
Hummingbird Bioscience and Endeavor BioMedicines (“Endeavor”), a clinical-stage company targeting the drivers of fibrosis and oncology, today announced that Endeavor has acquired exclusive worldwide rights to Hummingbird Bio’s antibody-drug conjugate (ADC), HMBD-501.
October 19, 2023
·
4 min read
Drug Development
Hummingbird Bioscience Announces Positive Phase I Clinical Data for HMBD-001 Monotherapy Trial at the European Society for Medical Oncology Congress 2023
Hummingbird Bioscience announced presentation of positive clinical data for the dose escalation part of the HMBD-001 Phase I/IIa trial at the European Society for Medical Oncology Congress 2023.
October 23, 2023
·
6 min read
1 of 3,788
Next
